<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>During cellular <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and <z:hpo ids='HP_0011420'>death</z:hpo>, many changes occur in the cell </plain></SENT>
<SENT sid="1" pm="."><plain>These include the build-up of <z:chebi fb="0" ids="35584">purines</z:chebi> and <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we evaluated the effectiveness of <z:chebi fb="0" ids="40279">allopurinol</z:chebi>, which blocks <z:chebi fb="0" ids="35584">purine</z:chebi> breakdown, and <z:chebi fb="0" ids="4356">deferoxamine</z:chebi>, which inhibits <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation, as cytoprotective agents </plain></SENT>
<SENT sid="3" pm="."><plain>Rats were subjected to middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> and were treated with high or low doses of <z:chebi fb="0" ids="40279">allopurinol</z:chebi> or high or low doses of <z:chebi fb="0" ids="4356">deferoxamine</z:chebi>, with <z:mpath ids='MPATH_458'>normal</z:mpath> saline used as a control </plain></SENT>
<SENT sid="4" pm="."><plain>Treatments were given 1 hour before, 1 hour after, or 5 hours after occlusion </plain></SENT>
<SENT sid="5" pm="."><plain>The outcome was based on neurological status and <z:mpath ids='MPATH_124'>infarct</z:mpath> size </plain></SENT>
<SENT sid="6" pm="."><plain>Both <z:mpath ids='MPATH_124'>infarct</z:mpath> size and neurological status were found to be improved in <z:hpo ids='HP_0000001'>all</z:hpo> treatment groups when compared to controls </plain></SENT>
<SENT sid="7" pm="."><plain>This study suggests that the use of these agents prevents cellular damage during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>